Literature DB >> 30091509

Impact of simulated MitraClip on forward flow obstruction in the setting of mitral leaflet tethering: An in vitro investigation.

Charles H Bloodworth1, Eric L Pierce1, Keshav Kohli1, Nancy J Deaton1, Kaitlin J Jones1, Radhika Duvvuri1, Norihiko Kamioka2, Vasilis C Babaliaros2, Ajit P Yoganathan1.   

Abstract

OBJECTIVES: We aimed to evaluate diastolic leaflet tethering as a factor that may cause mitral stenosis (MS) after simulated MitraClip implantation, using an in vitro left heart simulator.
BACKGROUND: Leaflet tethering commonly seen in functional mitral regurgitation may be a significant factor affecting the severity of MS after MitraClip implantation.
METHODS: A left heart simulator with excised ovine mitral valves (N = 6), and custom edge-to-edge clip devices (GTclip) was used to mimic implantation of MitraClip in a variety of positions. Anterior mitral leaflet (AML) tethering severity was varied for each case (leaflet excursion of 75°, 60°, and 45°, consistent with mild, moderate and severe tethering), and the baseline mitral annular area (MAA) was varied across samples (3.6-4.8 cm2 ). The resulting mitral valve area (MVA), and peak/mean mitral valve gradient (MVG) were measured in each case.
RESULTS: AML tethering severity was a highly significant factor increasing MVG and decreasing MVA (P < 0.001). When GTclip placement was simulated with severe AML tethering, mean MVG >5 mmHg resulted more frequently than with GTclip placement alone (46% vs. 4%, respectively). However, severe AML tethering alone significantly reduced baseline MVA to 3.6 ± 0.2 cm2 , and increased baseline MVG to 3.0 ± 0.4 mmHg. At MAA above 4.7 cm2 , severe AML tethering did not cause moderate MS, even with placement of two GTclips (95% confidence).
CONCLUSIONS: Our results show that diastolic AML tethering may predispose to MS after clip placement, however, MS was not observed when baseline MVA was above 4.0 cm2 . Severity of AML tethering may be an important criterion in selecting patients for edge-to-edge repair.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alfieri stitch; edge-to-edge; mitral stenosis; transcatheter mitral valve repair

Mesh:

Year:  2018        PMID: 30091509      PMCID: PMC6195822          DOI: 10.1002/ccd.27692

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  20 in total

1.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.

Authors:  Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Arturo Evangelista; Brian P Griffin; Bernard Iung; Catherine M Otto; Patricia A Pellikka; Miguel Quiñones
Journal:  J Am Soc Echocardiogr       Date:  2009-01       Impact factor: 5.251

2.  Peak mechanical loads induced in the in vitro edge-to-edge repair of posterior leaflet flail.

Authors:  Jean-Pierre M Rabbah; Andrew W Siefert; Erin M Spinner; Neelakantan Saikrishnan; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2012-06-28       Impact factor: 4.330

Review 3.  Mechanics of mitral valve edge-to-edge-repair and MitraClip procedure.

Authors:  Shamik Bhattacharya; Zhaoming He
Journal:  J Long Term Eff Med Implants       Date:  2015

4.  Assessing the Balance Between Less Mitral Regurgitation and More Residual Transmitral Pressure Gradient After MitraClip.

Authors:  Ted Feldman; Mayra Guerrero
Journal:  JACC Cardiovasc Interv       Date:  2017-05-08       Impact factor: 11.195

Review 5.  Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation.

Authors:  Jason H Rogers; Olaf Franzen
Journal:  Eur Heart J       Date:  2011-05-23       Impact factor: 29.983

6.  Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.

Authors:  Michael Neuss; Thomas Schau; Akihiro Isotani; Markus Pilz; Maren Schöpp; Christian Butter
Journal:  JACC Cardiovasc Interv       Date:  2017-05-08       Impact factor: 11.195

7.  In vitro and in silico approaches to quantify the effects of the Mitraclip® system on mitral valve function.

Authors:  Francesco Sturla; Riccardo Vismara; Michal Jaworek; Emiliano Votta; Paolo Romitelli; Omar A Pappalardo; Federico Lucherini; Carlo Antona; Gianfranco B Fiore; Alberto Redaelli
Journal:  J Biomech       Date:  2016-11-10       Impact factor: 2.712

8.  Real-world experience of MitraClip for treatment of severe mitral regurgitation.

Authors:  Pak Hei Chan; Hoi Lam She; Eduardo Alegria-Barrero; Neil Moat; Carlo Di Mario; Olaf Franzen
Journal:  Circ J       Date:  2012-07-03       Impact factor: 2.993

9.  In vitro mitral valve simulator mimics systolic valvular function of chronic ischemic mitral regurgitation ovine model.

Authors:  Andrew W Siefert; Jean Pierre M Rabbah; Kevin J Koomalsingh; Steven A Touchton; Neelakantan Saikrishnan; Jeremy R McGarvey; Robert C Gorman; Joseph H Gorman; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2013-01-29       Impact factor: 4.330

10.  Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.

Authors:  D Scott Lim; Matthew R Reynolds; Ted Feldman; Saibal Kar; Howard C Herrmann; Andrew Wang; Patrick L Whitlow; William A Gray; Paul Grayburn; Michael J Mack; Donald D Glower
Journal:  J Am Coll Cardiol       Date:  2013-10-31       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.